Similarly, CXD101, a class 1 HDAC inhibitor, enhances CD4+ and CD8+ T-cell infiltration in the TME by affecting immune-relevant gene expression in human colorectal cancer (CRC) cell lines 121. Here, CD8A is linked to colorectal carcinoma.